Related Experiment Video

Updated: Nov 2, 2025

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

4.0K

Improving clinical paediatric research and learning from COVID-19: recommendations by the Conect4Children

Athimalaipet V Ramanan1,2, Neena Modi3,4, Saskia N de Wildt5,6

  • 1University Hospitals Bristol NHS Foundation Trust, Bristol, UK. avramanan@hotmail.com.

Pediatric Research
|June 8, 2021
PubMed

Insights

The COVID-19 pandemic accelerated pediatric clinical research innovations. The Conect4children network recommends retaining these advancements to improve efficiency and equity in pediatric medicine development.

Area of Science:

  • Paediatric medicine development
  • Clinical research methodology
  • Public health and healthcare systems

Background:

  • The COVID-19 pandemic significantly impacted healthcare, driving innovation in clinical research, particularly for pediatric populations.
  • The Conect4children (c4c) network, a European collaboration of academic and industry partners, focuses on facilitating new medicine development for children.
  • c4c comprises 35 academic and 10 industry partners across 20 European countries, involving over 50 third parties and approximately 500 affiliated partners.

Purpose of the Study:

  • To summarize key aspects of pediatric clinical research stimulated by COVID-19.
  • To recommend practices for regulators, sponsors, and investigators to enhance future pediatric studies.
  • To improve the efficiency, reduce costs and burden, and ensure research equity in pediatric medicine and non-interventional studies.

Main Methods:

  • Review and synthesis of pediatric clinical research practices influenced by the COVID-19 pandemic.
  • Incorporation of industry perspectives, regulatory considerations, and infrastructure requirements.
  • Inclusion of parent-patient-public involvement in the evaluation of research innovations.

Main Results:

  • Identification of research innovations in pediatrics spurred by the pandemic.
  • Development of recommendations for enhancing the efficiency and equity of pediatric clinical trials.
  • Assessment of progress in international harmonization of pediatric research.

Conclusions:

  • Lessons learned from COVID-19 pediatric studies offer opportunities to improve future research.
  • Retaining pandemic-driven innovations can lead to more efficient, cost-effective, and equitable pediatric medicine development.
  • Continued international collaboration and harmonization are crucial for advancing pediatric research globally.
Abstract

More Related Videos

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

5.1K
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

51.0K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
55
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.9K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.0K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
70
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
68